Purchases and Sales Made in Q4 2024 in Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID) during Q4 2024. The information is specifically focused on institutions that hold shares of Ovid Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
17.2K+ 83.91% |
$16K - $23.4K
|
37.6K
$25.6K
|
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
15.4K+ 22.34% |
$14.3K - $20.9K
|
84.1K
$57.2K
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
1.75K+ 541.8% |
$1.63K - $2.38K
|
2.07K
$1.41K
|
|
|
Feb 04, 2025
Q4 2024
|
Capital Advisors, Ltd. LLC
|
BUY
|
- |
1.71KNew |
$1.59K - $2.33K
|
1.71K
$1.16K
|
|
|
Feb 04, 2025
Q4 2024
|
Ifp Advisors, Inc
|
BUY
|
- |
8New |
$7.44 - $10.9
|
8
$5.44
|
|
|
Jan 28, 2025
Q4 2024
|
Empowered Funds, LLC
|
SELL
|
- |
-6.93K- 4.76% |
$6.44K - $9.42K
|
138K
$94.1K
|
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-16.2K- 18.75% |
$15K - $22K
|
70.1K
$47.7K
|